Investors focused on the Medical space have likely heard of Cerner (CERN - Free Report) , but is the stock performing well in comparison to the rest of its sector peers? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.
Cerner is one of 844 individual stocks in the Medical sector. Collectively, these companies sit at #3 in the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.
The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. CERN is currently sporting a Zacks Rank of #1 (Strong Buy).
Over the past three months, the Zacks Consensus Estimate for CERN's full-year earnings has moved 2.97% higher. This shows that analyst sentiment has improved and the company's earnings outlook is stronger.
Based on the most recent data, CERN has returned 34.10% so far this year. At the same time, Medical stocks have gained an average of 1.94%. This shows that Cerner is outperforming its peers so far this year.
Breaking things down more, CERN is a member of the Medical Info Systems industry, which includes 20 individual companies and currently sits at #60 in the Zacks Industry Rank. On average, stocks in this group have gained 24.89% this year, meaning that CERN is performing better in terms of year-to-date returns.
Going forward, investors interested in Medical stocks should continue to pay close attention to CERN as it looks to continue its solid performance.